Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
Song MK, Chung JS, Lee JJ, Min CK, Ahn JS, Lee SM, Shin DY, Bae SH, Hong J, Lee GW, Lee IS, Shin HJ. Song MK, et al. Among authors: hong j. Br J Haematol. 2014 Jun;165(6):777-85. doi: 10.1111/bjh.12820. Epub 2014 Mar 15. Br J Haematol. 2014. PMID: 24628463 Free article.
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea.
Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, Hong J, Shin HJ, Lee JH, Mun YC, Min CK. Lee HS, et al. Among authors: hong j. Biomed Res Int. 2014;2014:253243. doi: 10.1155/2014/253243. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24995279 Free PMC article.
Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.
Lee GW, Go SI, Kim SH, Hong J, Kim YR, Oh S, Kim SY, Do YR, Lee H, Lee SI, Bae SH, Oh SY, Song MK, Lee WS, Lee B, Kim JS, Kim MK, Kang HJ, Ahn JS, Yhim HY, Kim HJ, Kim SJ, Kim WS, Suh C; Consortium for Improving Survival of Lymphoma (CISL) study group. Lee GW, et al. Among authors: hong j. Leuk Lymphoma. 2015 Apr;56(4):1020-6. doi: 10.3109/10428194.2014.946027. Epub 2014 Aug 20. Leuk Lymphoma. 2015. PMID: 25039351
Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma.
Jang HR, Song MK, Chung JS, Yang DH, Lee JO, Hong J, Cho SH, Kim SJ, Shin DH, Park YJ, Kang JS, Lee JE, Lee MW, Shin HJ. Jang HR, et al. Among authors: hong j. Blood Res. 2015 Jun;50(2):97-102. doi: 10.5045/br.2015.50.2.97. Epub 2015 Jun 25. Blood Res. 2015. PMID: 26157779 Free PMC article.
Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.
Koh MS, Kim WS, Kim SJ, Oh SY, Yoon DH, Lee SI, Hong J, Song MK, Shin HJ, Kwon JH, Kim HJ, Do YR, Suh C, Kim HJ. Koh MS, et al. Among authors: hong j. Int J Hematol. 2015 Oct;102(4):420-5. doi: 10.1007/s12185-015-1845-6. Epub 2015 Jul 26. Int J Hematol. 2015. PMID: 26210384 Clinical Trial.
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.
Oh SY, Kim WS, Kim JS, Chae YS, Lee GW, Eom HS, Ryoo HM, Lee S, Kim SJ, Yoon DH, Won JH, Hong J, Park J, Lee SM, Hong JY, Park E, Kim HJ, Yang DH, Kim HJ, Suh C. Oh SY, et al. Among authors: hong jy, hong j. Leuk Lymphoma. 2016;57(6):1406-12. doi: 10.3109/10428194.2015.1099650. Epub 2015 Nov 16. Leuk Lymphoma. 2016. PMID: 26413982 Clinical Trial.
15,854 results
You have reached the last available page of results. Please see the User Guide for more information.